HEALTH CARE DATA INFORMATION ACCESS, PRIVACY ISSUES ARE UNDER DEBATE ON THE HILL; SENATE, HOUSE MEASURES SEEK TO STRENGTHEN SECURITIES IN HEALTH REFORM
Executive Summary
The issues of data collection, security and privacy of health care information are receiving increasing attention on Capitol Hill and elsewhere as the debate on health care reform continues. In both the House and the Senate, debate is under way about how to reconcile the increased information needs of a reformed health care system with the right to privacy and the security of health care data.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth